candidate genes is human canceronida, including the TP53 gene known as the “tumor suppressor gene”,
“genome keeper” or “cell keeper o f growth and division”, which is located on - 17p13.1 chromosome.
The question of the study of the formation and development of this disease is currently a topical prob
lem of modern medicine. Various endogen and exogen changes are important in improving breast cancer
treatment. Also, the study of biochemical analysis o f peripheral blood is becoming a reliable criterion for
assessing human health.
The purpose of the work.
To analyze the association o f biochemical and TP53 gene rs17884159
polymorphism in the development of breast cancer.
Materials and methods.
For the study, 54 women were diagnosed with breast cancer. The results
of biochemical analysis BA88A (Mindray, Kitay) in the semi-automatic biochemical analyzer were deter
mined using the test-kits prepared for biochemical analysis of HUMAN (Human GMBH; Germany) from
the peripheral blood o f patients. Quantitative indicators of the general blood test were checked in the he
matological analyzer Mindray (China) or Sysmex. The studied samples were separated from the peripheral
blood by DNA using “Amplipraym ribo-prep” (OOO “Nekst Bio”, Russia) and “Diatom TM DNA Prep
100” (laboratory izogen, Russia). The amount and quality of DNA was checked using a NanoDrop 2000
(Thermo Fisher Scientific, USA) spectrophotometer. The C/T polymorphism o f the TP53 gene was tested
using the Sintol genetic test kit according to the the manufacturer’s instructions. The polymer chain reaction
was performed in a Rotor-Gene Q amplifier Gene Q (QIAGEN Hilden, Germany). Statistical analysis of
the obtained results were carried out using statistical computer programs “WinPEPI 2016, Version 11.65”
Do'stlaringiz bilan baham: |